Literature DB >> 31172422

Optimizing Drug Therapies in Patients with COPD in the US Nursing Home Setting.

Roy A Pleasants1,2, Peter A Radlowski3, H Edward Davidson4,5.   

Abstract

Chronic obstructive pulmonary disease (COPD) can be a disabling disease, and the impact on older adults is particularly evident in the nursing home setting. Chronic obstructive pulmonary disease is present in about 20% of nursing home residents, most often in women, and accounts for significant healthcare utilization including acute care visits for exacerbations and pneumonia, as well as worsening heart disease and diabetes mellitus. The emphasis on hospital readmissions is particularly important in nursing homes where institutions have quality measures that have financial implications. Optimizing drug therapies in individuals with COPD involves choosing medications that not only improve symptoms, but also decrease the risk of exacerbations. Optimizing the treatment of comorbidities such as heart disease, infections, and diabetes that may affect COPD outcomes is also an important consideration. Depending on the nursing home setting and the patient, the options for optimizing COPD drug therapies may be limited owing to patient-related factors such as cognition and physical impairment or available resources, primarily reimbursement-related issues. Choosing the best drug therapy for COPD in older adults is limited by the difficulty in assessing respiratory symptoms using standardized assessment tools and potentially decreased inspiratory ability of frail individuals. Because of cognitive and physical impediments, ensuring optimal delivery of inhaled medications into the lungs has significant challenges. Long-acting bronchodilators, inhaled corticosteroids, and roflumilast decrease the risk of exacerbations, although inhaled corticosteroids should be used judiciously in this population because of the risk of pneumonia and oropharyngeal side effects. Treatment of COPD exacerbations should occur early and consideration should be made to the benefits and risks of systemic corticosteroids and antibiotics. Clinical research in the COPD population in nursing homes is clearly lacking, and ripe for discovery of effective management strategies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31172422     DOI: 10.1007/s40266-019-00680-x

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  69 in total

1.  Longitudinal effects of aging on lung function at rest and exercise in healthy active fit elderly adults.

Authors:  S R McClaran; M A Babcock; D F Pegelow; W G Reddan; J A Dempsey
Journal:  J Appl Physiol (1985)       Date:  1995-05

2.  Chronic obstructive pulmonary disease: a disease of older persons.

Authors:  John E Morley
Journal:  J Am Med Dir Assoc       Date:  2014-03       Impact factor: 4.669

3.  Characteristics predicting incorrect metered-dose inhaler technique in older subjects.

Authors:  S L Gray; D M Williams; C C Pulliam; M A Sirgo; A L Bishop; J F Donohue
Journal:  Arch Intern Med       Date:  1996-05-13

4.  The role of cognitive impairment in the use of the Diskus inhaler.

Authors:  Malcolm Fraser; Meenakshi Patel; Edward Paul Norkus; Cyndi Whittington
Journal:  J Am Med Dir Assoc       Date:  2011-05-31       Impact factor: 4.669

5.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

Review 6.  2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

Authors:  Lenore Buckley; Gordon Guyatt; Howard A Fink; Michael Cannon; Jennifer Grossman; Karen E Hansen; Mary Beth Humphrey; Nancy E Lane; Marina Magrey; Marc Miller; Lake Morrison; Madhumathi Rao; Angela Byun Robinson; Sumona Saha; Susan Wolver; Raveendhara R Bannuru; Elizaveta Vaysbrot; Mikala Osani; Marat Turgunbaev; Amy S Miller; Timothy McAlindon
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-06-06       Impact factor: 4.794

Review 7.  Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.

Authors:  Robert Barrons; Angela Pegram; Alaina Borries
Journal:  Am J Health Syst Pharm       Date:  2011-07-01       Impact factor: 2.637

8.  Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?

Authors:  Piergiuseppe Agostoni; Mauro Contini; Gaia Cattadori; Anna Apostolo; Susanna Sciomer; Maurizio Bussotti; Pietro Palermo; Cesare Fiorentini
Journal:  Eur J Heart Fail       Date:  2007-06-11       Impact factor: 15.534

Review 9.  Frailty in elderly people.

Authors:  Andrew Clegg; John Young; Steve Iliffe; Marcel Olde Rikkert; Kenneth Rockwood
Journal:  Lancet       Date:  2013-02-08       Impact factor: 79.321

10.  The prevalence, characteristics, and impact of chronic obstructive pulmonary disease in North Carolina.

Authors:  Roy A Pleasants; Harry Herrick; Winston Liao
Journal:  N C Med J       Date:  2013 Sep-Oct
View more
  2 in total

1.  Groping around in the dark for adequate COPD management: a qualitative study on experiences in long-term care.

Authors:  Sara Lundell; Ulla-Maija Pesola; André Nyberg; Karin Wadell
Journal:  BMC Health Serv Res       Date:  2020-11-10       Impact factor: 2.655

Review 2.  Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD.

Authors:  Donald P Tashkin; Xiaoli Niu; Sanjay Sharma; Shahin Sanjar
Journal:  NPJ Prim Care Respir Med       Date:  2021-10-07       Impact factor: 2.871

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.